Journal
PHARMACOECONOMICS
Volume 32, Issue 12, Pages 1153-1155Publisher
ADIS INT LTD
DOI: 10.1007/s40273-014-0200-8
Keywords
-
Ask authors/readers for more resources
Resources devoted to the development of burden-of-disease studies detract from much needed cost-effectiveness and cost-benefit studies. Practitioners need to help funders of burden-of-disease projects recognize the potential of all tools of decision analysis and economic evaluation in improving the efficiency and equity for the health care system.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available